{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:34:22Z","timestamp":1792704862575,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001081","name":"Hunter Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ajog.2016.08.027","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T10:36:54Z","timestamp":1472467014000},"page":"283.e1-283.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor"],"prefix":"10.1016","volume":"216","author":[{"given":"Jonathan W.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ilicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge M.","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2016.08.027_bib1","unstructured":"Preterm birth. WHO fact sheet no 363.\u00a02015."},{"key":"10.1016\/j.ajog.2016.08.027_bib2","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajog.2016.08.027_bib3","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2010.11.038","article-title":"Nifedipine for the management of preterm labor: a systematic review and metaanalysis","volume":"204","author":"Conde-Agudelo","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0031-1284227","article-title":"Indomethacin in pregnancy: applications and safety","volume":"29","author":"Abou-Ghannam","year":"2012","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2016.08.027_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1515\/JPM.2006.073","article-title":"European Association of Perinatal Medicine-Study Group on Preterm Birth. Guidelines for the management of spontaneous preterm labor","volume":"34","author":"Di Renzo","year":"2006","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2016.08.027_bib6","first-page":"1020","article-title":"The management of preterm labor","volume":"100","author":"Goldenberg","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e318199924a","article-title":"Tocolytic therapy: a meta-analysis and decision analysis","volume":"113","author":"Haas","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/13543784.2014.905541","article-title":"Preterm labor: association between labor physiology, tocolysis and prevention","volume":"23","author":"Illanes","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ajog.2016.08.027_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/14656566.2014.880110","article-title":"Preterm labor: current tocolytic options for the treatment of preterm labor","volume":"15","author":"Jorgensen","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajog.2016.08.027_bib10","doi-asserted-by":"crossref","first-page":"e6226","DOI":"10.1136\/bmj.e6226","article-title":"Tocolytic therapy for preterm delivery: systematic review and network meta-analysis","volume":"345","author":"Haas","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.08.027_bib11","first-page":"Cd003249","article-title":"Treatment for primary postpartum hemorrhage","volume":"1","author":"Mousa","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"10.1016\/j.ajog.2016.08.027_bib12","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0928-0987(00)00166-4","article-title":"Drug targeting","volume":"11","author":"Torchilin","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajog.2016.08.027_bib13","doi-asserted-by":"crossref","first-page":"b744","DOI":"10.1136\/bmj.b744","article-title":"Adverse drug reactions to tocolytic treatment for preterm labor: prospective cohort study","volume":"338","author":"de Heus","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.08.027_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0002-9378(94)70214-4","article-title":"The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human","volume":"170","author":"Goodwin","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/mob.2000.95834","article-title":"An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue","volume":"182","author":"Romero","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib16","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0002-9378(11)90763-7","article-title":"Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use","volume":"168","author":"Moise","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mob.2002.127464","article-title":"The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate","volume":"187","author":"Suarez","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9378(97)70184-4","article-title":"The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age","volume":"177","author":"Vermillion","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib19","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ajog.2016.08.027_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","article-title":"Nanotech approaches to drug delivery and imaging","volume":"8","author":"Sahoo","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ajog.2016.08.027_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1208\/s12248-012-9330-0","article-title":"Challenges in development of targeted liposomal therapeutics","volume":"14","author":"Sawant","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.ajog.2016.08.027_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0169-409X(98)00095-7","article-title":"Liposomes for scintigraphic detection of infection and inflammation","volume":"37","author":"Laverman","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajog.2016.08.027_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajog.2016.08.027_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1099-1352(199634\/12)9:5\/6<335::AID-JMR309>3.0.CO;2-0","article-title":"Affinity liposomes in\u00a0vivo: factors influencing target accumulation","volume":"9","author":"Torchilin","year":"1996","journal-title":"J\u00a0Mol Recognit"},{"key":"10.1016\/j.ajog.2016.08.027_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1020178304031","article-title":"Biophysical aspects of using liposomes as delivery vehicles","volume":"22","author":"Ulrich","year":"2002","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ajog.2016.08.027_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajog.2016.08.027_bib27","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","volume":"7","author":"Chang","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajog.2016.08.027_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/08982101003754401","article-title":"Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes","volume":"21","author":"Hua","year":"2011","journal-title":"J\u00a0Liposome Res"},{"key":"10.1016\/j.ajog.2016.08.027_bib29","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.36076\/ppj.2013\/16\/E199","article-title":"Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition","volume":"16","author":"Hua","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.ajog.2016.08.027_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0002-9378(84)90677-X","article-title":"Oxytocin receptors in the human uterus during pregnancy and parturition","volume":"150","author":"Fuchs","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/joe.0.1610143","article-title":"Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labor","volume":"161","author":"Wathes","year":"1999","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ajog.2016.08.027_bib32","first-page":"1808","article-title":"Inhibition of uterine contractions by rolipram in\u00a0vitro","volume":"38","author":"Loge","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ajog.2016.08.027_bib33","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1210\/en.2008-0593","article-title":"Evidence that a protein kinase A substrate, small heat-shock protein 20, modulates myometrial relaxation in human pregnancy","volume":"149","author":"Tyson","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2016.08.027_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1447-0756.2012.01929.x","article-title":"Uterus-relaxing effect of beta2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in\u00a0vivo and on pregnant human myometrium in\u00a0vitro","volume":"39","author":"Verli","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2016.08.027_bib35","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1113\/jphysiol.2009.171272","article-title":"Loss of functional K+ channels encoded by ether-a-go-go-related genes in mouse myometrium prior to labor onset","volume":"587","author":"Greenwood","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ajog.2016.08.027_bib36","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1038\/ncomms5108","article-title":"Diminished hERG K channel activity facilitates strong human labor contractions but is dysregulated in obese women","volume":"5","author":"Parkington","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2016.08.027_bib37","doi-asserted-by":"crossref","first-page":"e21542","DOI":"10.1371\/journal.pone.0021542","article-title":"Phasic phosphorylation of caldesmon and ERK 1\/2 during contractions in human myometrium","volume":"6","author":"Paul","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2016.08.027_bib38","doi-asserted-by":"crossref","first-page":"155.e151","DOI":"10.1016\/j.ajog.2011.03.014","article-title":"Methodology and pharmacological analysis of effects of uterotonic compounds in human myometrium in\u00a0vitro","volume":"205","author":"Crankshaw","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-2952(89)90142-1","article-title":"Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term","volume":"38","author":"Leroy","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2016.08.027_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002109900092","article-title":"Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium","volume":"360","author":"Bardou","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ajog.2016.08.027_bib41","first-page":"40","article-title":"Liposomes (a review). Part 2: drug delivery systems","volume":"17","author":"Chrai","year":"2002","journal-title":"BioPharm"},{"key":"10.1016\/j.ajog.2016.08.027_bib42","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1210\/endo.136.9.7649111","article-title":"Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization","volume":"136","author":"Adan","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2016.08.027_bib43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/0256-4947.67079","article-title":"Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial","volume":"30","author":"Motazedian","year":"2010","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.ajog.2016.08.027_bib44","first-page":"CD004352","article-title":"Betamimetics for inhibiting preterm labor","volume":"2","author":"Neilson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2016.08.027_bib45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3109\/14767050903572182","article-title":"Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labor and hypertension: a systematic review and meta-regression analysis","volume":"23","author":"Khan","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2016.08.027_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1471-0528.2004.00480.x","article-title":"Severe hypotension and fetal death due to tocolysis with nifedipine","volume":"112","author":"van Veen","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.08.027_bib47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1471-0528.2005.00752.x","article-title":"Severe hypotension and fetal death due to tocolysis with nifedipine","volume":"112","author":"Papatsonis","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.08.027_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9378(93)90138-9","article-title":"Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study","volume":"169","author":"Morales","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib49","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2003.255","article-title":"A\u00a0double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor","volume":"188","author":"Sawdy","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib50","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1055\/s-0036-1579647","article-title":"Perinatal outcomes after short versus prolonged indomethacin for tocolysis in women with preterm labor","volume":"33","author":"Dutta","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2016.08.027_bib51","doi-asserted-by":"crossref","first-page":"505.e501","DOI":"10.1016\/j.ajog.2014.10.1091","article-title":"Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis","volume":"212","author":"Hammers","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib52","first-page":"508.e501","article-title":"Liposomes: a nanoscale drug carrying system to prevent indomethacin passage to the fetus in a pregnant mouse model","volume":"212","author":"Refuerzo","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib53","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4049\/jimmunol.178.2.1115","article-title":"PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation","volume":"178","author":"Schmitz","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2016.08.027_bib54","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.08.027_bib55","doi-asserted-by":"crossref","first-page":"63.e61","DOI":"10.1016\/j.ajog.2011.07.030","article-title":"Peripartum hysterectomy in the United States: nationwide 14 year experience","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib56","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/AOG.0000000000000021","article-title":"Massive blood transfusion during hospitalization for delivery in New York state, 1998-2007","volume":"122","author":"Mhyre","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib57","doi-asserted-by":"crossref","first-page":"353.e351","DOI":"10.1016\/j.ajog.2010.01.011","article-title":"Trends in postpartum hemorrhage: United States, 1994-2006","volume":"202","author":"Callaghan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib58","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2008.01859.x","article-title":"Prevalence and risk factors of severe obstetric hemorrhage","volume":"115","author":"Al-Zirqi","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.08.027_bib59","doi-asserted-by":"crossref","first-page":"642.e641","DOI":"10.1016\/j.ajog.2015.01.008","article-title":"Second-line uterotonics and the risk of hemorrhage-related morbidity","volume":"212","author":"Butwick","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mob.2003.22","article-title":"Oxytocin-induced desensitization of the oxytocin receptor","volume":"188","author":"Robinson","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.08.027_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1540\/jsmr.31.175","article-title":"The regulation of oxytocin receptor expression in human myometrial monolayer culture","volume":"31","author":"Adachi","year":"1995","journal-title":"J\u00a0Smooth Muscle Res"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816305920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816305920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:03Z","timestamp":1762079643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816305920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0002937816305920"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.08.027","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s43032-025-01864-0","asserted-by":"object"},{"id-type":"doi","id":"10.1007\/s43032-025-01941-4","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}